Literature DB >> 23186870

Prolyl 3-hydroxylase-1 null mice exhibit hearing impairment and abnormal morphology of the middle ear bone joints.

Elena Pokidysheva1, Sara Tufa, Chris Bresee, John V Brigande, Hans Peter Bächinger.   

Abstract

Prolyl 3-hydroxylase1 (P3H1) is a collagen modifying enzyme which hydroxylates certain prolines in the Xaa position of conventional GlyXaaYaa triple helical sequence. Recent investigations have revealed that mutations in the LEPRE1 (gene encoding for P3H1) cause severe osteogenesis imperfecta (OI) in humans. Similarly LEPRE1 knockout mice display an OI-like phenotype. Significant hearing loss is a common problem for people with osteogenesis imperfecta. Here we report that hearing of the P3H1 null mice is substantially affected. Auditory brainstem responses (ABRs) of the P3H1 null mice show an average increase of 20-30 dB in auditory thresholds. Three dimensional reconstructions of the mutant middle ear bones by Micro-scale X-ray computed tomography (Micro-CT) demonstrate abnormal morphology of the incudostapedial and incudomalleal joints. We establish the LEPRE1 knockout mouse as a valuable model system to investigate the mechanism of hearing loss in recessive OI.
Copyright © 2012 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23186870      PMCID: PMC3570717          DOI: 10.1016/j.matbio.2012.11.006

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  30 in total

1.  How common is hearing impairment in osteogenesis imperfecta?

Authors:  C R Paterson; E A Monk; S J McAllion
Journal:  J Laryngol Otol       Date:  2001-04       Impact factor: 1.469

2.  An evaluation of otopathology in the MOV-13 transgenic mutant mouse.

Authors:  R A Altschuler; D F Dolan; M Ptok; G Gholizadeh; J Bonadio; J E Hawkins
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

3.  Histopathology of the stapes in osteogenesis imperfecta.

Authors:  U Pedersen; F Melsen; O Elbrønd; P Charles
Journal:  J Laryngol Otol       Date:  1985-05       Impact factor: 1.469

4.  Hearing and middle ear function in osteogenesis imperfecta.

Authors:  J R Shapiro; A Pikus; G Weiss; D W Rowe
Journal:  JAMA       Date:  1982-04-16       Impact factor: 56.272

5.  Classification of osteogenesis imperfect.

Authors:  D O Sillence; D L Rimoin
Journal:  Lancet       Date:  1978-05-13       Impact factor: 79.321

6.  Hearing loss in Finnish adults with osteogenesis imperfecta: a nationwide survey.

Authors:  Kaija Kuurila; Ilkka Kaitila; Reijo Johansson; Reidar Grénman
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-10       Impact factor: 1.547

7.  Development of absolute auditory thresholds in the house mouse (Mus musculus).

Authors:  G Ehret
Journal:  J Am Audiol Soc       Date:  1976 Mar-Apr

8.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

9.  Association of COL1A1 and otosclerosis: evidence for a shared genetic etiology with mild osteogenesis imperfecta.

Authors:  M J McKenna; A G Kristiansen; M L Bartley; J J Rogus; J L Haines
Journal:  Am J Otol       Date:  1998-09

10.  Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen.

Authors:  Ulrike Schwarze; Tim Cundy; Shawna M Pyott; Helena E Christiansen; Madhuri R Hegde; Ruud A Bank; Gerard Pals; Arunkanth Ankala; Karen Conneely; Laurie Seaver; Suzanne M Yandow; Ellen Raney; Dusica Babovic-Vuksanovic; Joan Stoler; Ziva Ben-Neriah; Reeval Segel; Sari Lieberman; Liesbeth Siderius; Aida Al-Aqeel; Mark Hannibal; Louanne Hudgins; Elizabeth McPherson; Michele Clemens; Michael D Sussman; Robert D Steiner; John Mahan; Rosemarie Smith; Kwame Anyane-Yeboa; Julia Wynn; Karen Chong; Tami Uster; Salim Aftimos; V Reid Sutton; Elaine C Davis; Lammy S Kim; Mary Ann Weis; David Eyre; Peter H Byers
Journal:  Hum Mol Genet       Date:  2012-09-04       Impact factor: 6.150

View more
  5 in total

Review 1.  Osteogenesis imperfecta: an update on clinical features and therapies.

Authors:  Ronit Marom; Brien M Rabenhorst; Roy Morello
Journal:  Eur J Endocrinol       Date:  2020-10       Impact factor: 6.664

2.  Characterization of the microRNA transcriptomes and proteomics of cochlear tissue-derived small extracellular vesicles from mice of different ages after birth.

Authors:  Pei Jiang; Xiangyu Ma; Shanying Han; Leyao Ma; Jingru Ai; Leilei Wu; Yuan Zhang; Hairong Xiao; Mengyao Tian; W Andy Tao; Shasha Zhang; Renjie Chai
Journal:  Cell Mol Life Sci       Date:  2022-02-26       Impact factor: 9.261

Review 3.  Collagen prolyl 3-hydroxylation: a major role for a minor post-translational modification?

Authors:  David M Hudson; David R Eyre
Journal:  Connect Tissue Res       Date:  2013-06-21       Impact factor: 3.417

4.  Substitution of murine type I collagen A1 3-hydroxylation site alters matrix structure but does not recapitulate osteogenesis imperfecta bone dysplasia.

Authors:  Wayne A Cabral; Nadja Fratzl-Zelman; MaryAnn Weis; Joseph E Perosky; Adrienne Alimasa; Rachel Harris; Heeseog Kang; Elena Makareeva; Aileen M Barnes; Paul Roschger; Sergey Leikin; Klaus Klaushofer; Antonella Forlino; Peter S Backlund; David R Eyre; Kenneth M Kozloff; Joan C Marini
Journal:  Matrix Biol       Date:  2020-02-26       Impact factor: 11.583

Review 5.  Collagen Biosynthesis, Processing, and Maturation in Lung Ageing.

Authors:  Ceylan Onursal; Elisabeth Dick; Ilias Angelidis; Herbert B Schiller; Claudia A Staab-Weijnitz
Journal:  Front Med (Lausanne)       Date:  2021-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.